About the selective-cultivation idea

Why cultivation?

Chelsea brings cultivated ground to my imagination. That association became more interesting when the alpha-MSH peptide experiment described reduced viability of a bacterium and a fungus. A research story about skin suddenly had several kinds of growth to consider.

I prefer a garden with some difficult questions in it. The KPV wound-gel study described antibacterial effects alongside inflammation control and repair. The macrophage experiment resisted a simple account of how an anti-inflammatory peptide behaves. Both make the subject more absorbing than a list of things expected to improve.

The garden is an analogy. It gives no biological authority to a claim, and it offers no plan for managing the organisms on anyone’s skin. I enjoy it most where an experiment complicates it: a different cell, a changed preparation or an outcome that refuses to move.

The publication’s scope

Chelsea Skin Clinic names this publication about published research. The name confers no clinical role on me. There is no treatment business here: no prescribing, no medicine supply or dispatch, and no appointments to arrange.

The essays are not medical advice. They cannot assess an individual’s skin, medical history or treatment. Personal care calls for a qualified health professional who can consider those circumstances.

The KPV work cited here comes from microbial cultures, other cell experiments, animal models and reviews of such research. Human cells in a dish can answer interesting biological questions while leaving human treatment questions open. I’m content to spend time on the former without pretending to settle the latter.

The reading list gathers the studies discussed on these pages. Correspondence information states the present limit on sending a correction.